Patient-reported Outcomes of Donor Site Healing Using Different Palatal Protection Techniques
Launched by VIRGINIA COMMONWEALTH UNIVERSITY · Mar 20, 2025
Trial Information
Current as of April 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the best ways to protect the roof of the mouth (the palate) after a gum graft procedure. Specifically, it aims to find out which method helps patients heal better after the graft has been removed. The researchers want to understand if different techniques for protecting the palate make a difference in how patients feel about their healing process.
To participate in this study, you need to be at least 18 years old and generally healthy, or have mild health issues that don’t affect your daily activities. You should also need a gum graft for 1 to 3 teeth or implants and have a certain thickness in your palate. However, people with certain health conditions, such as diabetes or bleeding disorders, or those who smoke, cannot take part in the trial. If you join, you can expect to follow specific instructions after your gum graft surgery and share your experiences regarding the healing process. Your input will help researchers understand the best ways to support healing for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • At least 18 years of age
- • Healthy or Mild controlled systemic diseases with no functional limitations (ASA I or ASA II)
- • Sites with 1 to 3 teeth or implants requiring soft-tissue grafting
- • Minimum palatal thickness of 2 mm
- • Willing to participate and sign an informed consent
- Exclusion Criteria:
- • Patients with systemic conditions that could impair wound healing (i.e. diabetes, immunosuppressive, chemotherapy, etc.)
- • Pregnant patients
- • Patients with bleeding disorders or taking anticoagulants
- • Smokers
- • Patients with a history of palatal graft harvesting
Trial Officials
Rafael Amorim Cavalcanti de Siqueira
Principal Investigator
Virginia Commonwealth University
About Virginia Commonwealth University
Virginia Commonwealth University (VCU) is a prominent academic institution and research leader located in Richmond, Virginia. Renowned for its commitment to advancing healthcare through innovative research and education, VCU plays a pivotal role in clinical trials aimed at improving patient outcomes and understanding complex health issues. The university boasts a collaborative environment, leveraging its diverse faculty expertise and state-of-the-art facilities to conduct rigorous clinical research across various medical disciplines. VCU's dedication to ethical research practices and community engagement ensures that its clinical trials are designed to address critical health challenges while prioritizing participant safety and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Richmond, Virginia, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported